BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31974378)

  • 21. Chronic alcohol consumption inhibits melanoma growth but decreases the survival of mice immunized with tumor cell lysate and boosted with α-galactosylceramide.
    Zhang F; Zhu Z; Meadows GG; Zhang H
    Int Immunopharmacol; 2015 Sep; 28(1):359-68. PubMed ID: 26118634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective stimulation of invariant natural killer T cells by oligomannose-coated liposomes.
    Ishii M; Kojima N
    Int Immunopharmacol; 2013 Apr; 15(4):685-92. PubMed ID: 23535021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo activation of invariant natural killer T cells induces systemic and local alterations in T-cell subsets prior to preterm birth.
    Gomez-Lopez N; Romero R; Arenas-Hernandez M; Schwenkel G; St Louis D; Hassan SS; Mial TN
    Clin Exp Immunol; 2017 Aug; 189(2):211-225. PubMed ID: 28369855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of leukotriene B4 12-hydroxydehydrogenase in α-galactosylceramide-pulsed dendritic cell therapy for non-small cell lung cancer.
    Tanaka K; Kanesaka Y; Takami M; Suzuki A; Hosokawa H; Onodera A; Kamata T; Nagato K; Nakayama T; Yoshino I; Motohashi S
    Biochem Biophys Res Commun; 2018 Nov; 506(1):27-32. PubMed ID: 30336981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
    Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
    Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.
    Schneiders FL; de Bruin RC; Santegoets SJ; Bonneville M; Scotet E; Scheper RJ; Verheul HM; de Gruijl TD; van der Vliet HJ
    Clin Immunol; 2012 Feb; 142(2):194-200. PubMed ID: 22122798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nano spray dryer for vectorizing α-galactosylceramide in polymeric nanoparticles: A single step process to enhance invariant Natural Killer T lymphocyte responses.
    Gonzatti MB; Sousa MEP; Tunissi AS; Mortara RA; de Oliveira AM; Pereira Cerize NN; Keller AC
    Int J Pharm; 2019 Jun; 565():123-132. PubMed ID: 31075434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma.
    Torres D; Paget C; Fontaine J; Mallevaey T; Matsuoka T; Maruyama T; Narumiya S; Capron M; Gosset P; Faveeuw C; Trottein F
    J Immunol; 2008 Jan; 180(2):783-92. PubMed ID: 18178816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation.
    Cullen R; Germanov E; Shimaoka T; Johnston B
    J Immunol; 2009 Nov; 183(9):5807-15. PubMed ID: 19812206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium chloride inhibits IFN-γ, but not IL-4, production by invariant NKT cells.
    Jeong D; Kim HY; Chung DH
    J Leukoc Biol; 2018 Jan; 103(1):99-106. PubMed ID: 29345057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells.
    Kanda M; Yamanaka H; Kojo S; Usui Y; Honda H; Sotomaru Y; Harada M; Taniguchi M; Suzuki N; Atsumi T; Wada H; Baghdadi M; Seino K
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3394-402. PubMed ID: 27226296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
    Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered invariant natural killer T cell subsets and its functions in patients with oral squamous cell carcinoma.
    Singh AK; Shukla NK; Das SN
    Scand J Immunol; 2013 Nov; 78(5):468-77. PubMed ID: 23980793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-operation of α-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model.
    Dong T; Yi T; Yang M; Lin S; Li W; Xu X; Hu J; Jia L; Hong X; Niu W
    Biochem J; 2016 Jan; 473(1):7-19. PubMed ID: 26450924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motility and tumor infiltration are key aspects of invariant natural killer T cell anti-tumor function.
    Tian C; Wang Y; Su M; Huang Y; Zhang Y; Dou J; Zhao C; Cai Y; Pan J; Bai S; Wu Q; Chen S; Li S; Xie D; Lv R; Chen Y; Wang Y; Fu S; Zhang H; Bai L
    Nat Commun; 2024 Feb; 15(1):1213. PubMed ID: 38332012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes.
    Gehrmann U; Hiltbrunner S; Georgoudaki AM; Karlsson MC; Näslund TI; Gabrielsson S
    Cancer Res; 2013 Jul; 73(13):3865-76. PubMed ID: 23658368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.
    Grajewski RS; Hansen AM; Agarwal RK; Kronenberg M; Sidobre S; Su SB; Silver PB; Tsuji M; Franck RW; Lawton AP; Chan CC; Caspi RR
    J Immunol; 2008 Oct; 181(7):4791-7. PubMed ID: 18802082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
    Yang G; Artiaga BL; Lewis ST; Driver JP
    Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
    Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
    Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.